CRIS Current Research Information System

FARABEGOLI, FULVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.182
AS - Asia 2.152
EU - Europa 1.654
AF - Africa 143
SA - Sud America 127
Continente sconosciuto - Info sul continente non disponibili 98
OC - Oceania 5
Totale 6.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.124
IT - Italia 637
CN - Cina 612
SG - Singapore 565
VN - Vietnam 453
GB - Regno Unito 240
DE - Germania 135
HK - Hong Kong 132
SE - Svezia 119
IN - India 103
BR - Brasile 94
FR - Francia 93
KR - Corea 87
CH - Svizzera 80
RU - Federazione Russa 62
IE - Irlanda 52
NL - Olanda 50
FI - Finlandia 46
BD - Bangladesh 43
CI - Costa d'Avorio 41
TG - Togo 40
CA - Canada 38
JP - Giappone 38
UA - Ucraina 30
NG - Nigeria 22
ZA - Sudafrica 19
EE - Estonia 18
BG - Bulgaria 17
TR - Turchia 17
ID - Indonesia 16
TW - Taiwan 15
TH - Thailandia 13
AR - Argentina 12
ES - Italia 12
GR - Grecia 12
IR - Iran 11
JO - Giordania 11
MX - Messico 11
PH - Filippine 11
AT - Austria 9
DK - Danimarca 9
PL - Polonia 9
BE - Belgio 6
AU - Australia 5
CL - Cile 5
PT - Portogallo 5
TN - Tunisia 5
EC - Ecuador 4
EG - Egitto 4
IQ - Iraq 4
MA - Marocco 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
DZ - Algeria 3
LT - Lituania 3
PK - Pakistan 3
RO - Romania 3
SA - Arabia Saudita 3
SC - Seychelles 3
CO - Colombia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CG - Congo 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
LB - Libano 1
ME - Montenegro 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
SI - Slovenia 1
SM - San Marino 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
Totale 6.265
Salva come PNG Salva come JPEG
Città #
Singapore 402
Ashburn 254
Bologna 196
Hefei 193
Southend 185
Chandler 177
Fairfield 156
San Jose 129
Hong Kong 118
Ho Chi Minh City 113
Santa Clara 109
Hanoi 98
Woodbridge 85
Seattle 84
Bern 75
Seoul 74
Houston 73
Wilmington 72
Beijing 68
Cambridge 55
Dublin 50
Princeton 49
Milan 48
Los Angeles 45
Dallas 43
Abidjan 41
Lomé 40
Helsinki 38
Boardman 37
Lauterbourg 36
Ann Arbor 32
Tokyo 32
New York 29
Redmond 29
Buffalo 26
Bengaluru 24
Nanjing 24
Abeokuta 21
Council Bluffs 21
Da Nang 21
Genoa 19
Westminster 19
Jacksonville 18
Guangzhou 17
Rome 17
Sofia 17
Dong Ket 16
Florence 16
Haiphong 16
Padova 16
San Diego 16
São Paulo 16
Turin 15
Jakarta 14
Montreal 14
Frankfurt am Main 13
Pune 13
Shanghai 12
Tianjin 12
Amman 11
Amsterdam 11
Forlì 11
London 11
Berlin 10
Changsha 10
Düsseldorf 10
Falkenstein 10
Shenyang 10
Ninh Bình 9
Toronto 9
Casatenovo 8
Copenhagen 8
Hyderabad 8
Jinan 8
Munich 8
Nanchang 8
Paris 8
Phoenix 8
Rimini 8
Saint Petersburg 8
Salt Lake City 8
Verona 8
Cesena 7
Dearborn 7
Exeter 7
Hải Dương 7
Mülheim 7
Redondo Beach 7
Vienna 7
Zhengzhou 7
Biên Hòa 6
Calcinelli 6
Carlsbad 6
Chicago 6
Claymont 6
Des Moines 6
Hebei 6
Istanbul 6
Laurel 6
Modena 6
Totale 4.022
Salva come PNG Salva come JPEG
Nome #
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer 363
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 282
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 277
Epigallocatechin-3-gallate and 6-OH-11-O-hydroxyphenanthrene limit BE(2)-C neuroblastoma cell growth and neurosphere formation in vitro 259
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity 251
Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells 246
EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion 235
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells 216
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 213
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 213
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines. 205
Differential enantiomers activity of ARN24089 to achieve synthetic lethality in pancreatic cancer 201
Large Population Of Homogeneous Spheroids Models For Testing Toxicity And Diffusion Of Nanomaterials 200
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 198
(-)-epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line 191
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC) 187
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines 184
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination 171
Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines 166
Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement 165
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma 159
SOCS-2 expression in MCF-7 and MDA-MB-231 cells 151
Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells 149
(-)-Epigallocatechin-3-gallate down regulates estrogen receptor alpha function in MCF-7 breast carcinoma cells 146
EGCG mediated targeting of deregulated signaling pathways and non-coding rnas in different cancers: Focus on JAK/STAT, Wnt/β-catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL mediated signaling pathways 146
Proteomic profile of BxPC-3 cells after treatment with BRC4 133
Trattamento di cellule MCF-7 resistenti al tamoxifene con (-)-epigallocatechina-3-gallato 132
Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy 127
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 122
Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma. 122
(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. 113
Green tea in human cancer 91
null 91
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in cancer treatment 88
XXI Convegno Annuale ABCD (Stress cellulare: sopravvivenza ed apoptosi), Atti convegno 87
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 81
Totale 6.361
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022445 0 16 34 41 27 27 10 47 14 22 101 106
2022/2023729 49 110 23 87 75 55 19 26 98 40 42 105
2023/2024374 61 38 14 42 21 46 41 31 11 16 20 33
2024/20251.028 59 99 79 74 152 55 67 26 35 78 87 217
2025/20262.488 268 271 233 262 238 105 244 89 440 144 94 100
2026/202797 70 27 0 0 0 0 0 0 0 0 0 0
Totale 6.361